Cancer Family
Skin Epithelial Neoplasm
CI-CAN-00000350Explore in graph →
Non-malignant138 active trials2 approved drugs4 evidence items
- NCIt
- C7342
Loading cancer entity…
Cancer Family
CI-CAN-00000350Explore in graph →
Clinical trials
451 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05358938 | Exercise to Boost Response to Checkpoint Blockade Immunotherapy | active not recruiting | Early Phase 1 | 22 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT03543969 | Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma | active not recruiting | Early Phase 1 | 14 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 5, 2026 |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials